Prostate cancer is the most frequent malignant tumor in men.
An early and accurate diagnosis will provide the most appropriate treatment.
The diagnosis involves a clinical interview, digital rectal
examination of the prostate, serum PSA levels (prostate specific antigen),
ultrasonography and, recently, a prostate MRI (magnetic resonance imaging).
This test is of utmost importance, as it reports the existence of suspicious
areas and their features (number, size, location). Whenever the suspicion of
cancer is high, a PROSTATE BIOPSY is mandatory. That implies to obtain small
prostatic samples for an anatomopathologic analysis, whic will provide the
definitive diagnosis (benign or malignant cells).
Typically this biopsy was performed “blindly” due
to the low discrimination capacity of the ultrasound identifying suspicious
areas within the prostate. We used to take samples trying to represent every
prostatic area (mapping biopsies). There was a high percentage of “false
negatives”, i.e., patients with a prostatic tumour not identified by the
biopsies.
The Fusion Prostate Biopsy combines the images from the
MRI and the ultrasound to create a detailed 3D image of the prostate. This
makes it easier to reach the abnormal areas and obtain more precise and
significant samples, thus optimizing the results. We decrese the false negative
ratio and better characterize patient’s disease.
The procedure is performed at the operating room under
sedation, lasting about 45 minutes and being discharged a few hours later.
The main advanteges of this fusion biopsy are:
-Higher rate of cancer detection compared to other types of
biopsies, having therapeutic implications.
–It reduces possible
complications, mainly infections, as it does not puncture through the rectum. Transperineal sampling also
helps to reach all areas even in large prostates.
-Active surveillance: this strategy can be adopted in certain
low risk tumours.
-Focal treatment: the aim is to destroy the lesion, avoiding
a radical treatment in wich the entire gland is removed.
-It is
possible to propose a HoLEP (Holmiun Laser Enucleation of the Prostate) in case
of negative biopsy (no malignancy) and presence of obstructive symptoms.